longbridge

000623

16.601.19%

JILIN AODONG: Yanbian Pharmaceutical passed the drug GMP compliance inspection

Zhitong
LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, JILIN AODONG (000623.SZ) announced that its holding subsidiary JILIN AODONG YANBIAN PHARMACEUTICAL CO., LTD. (referred to as "Yanbian Pharmaceutical") has received the "Drug GMP Compliance Inspection Notice" approved and issued by the Jilin Provincial Drug Administration

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

© 2026 Longbridge｜Terms of ServicePrivacy Policy